MHH Logo
Medizinische Hochschule Hannover | Carl-Neuberg-Str.1 | 30625 Hannover | Tel.:(+49) 0511-532-0

2009 -

Carney, L., Pierce, A., Rjinen, M., Gonzalez-Sachez M. B., Hamzah, H. G., Zhang, L., Tamura, T., and Whetton, A. D. (2009) THOC5 couples M-CSF receptor signalling to transcription factor expression. Cell. Signalling, 21: 209-316.

 El Bounkari, O., Guria, A.,  Klebba-Faerber, S., Claußen, M., Pieler, T., Griffiths, J.R., Whetton, A. D., Koch, A., and Tamura.T. (2009) Nuclear localization of the pre-mRNA associating protein, THOC7 depends upon its direct interaction with Fms tyrosine kinase interacting protein (FMIP). FEBS Letter, 583, 13-18.

Tossidou I, Dangers M, Koch A, Brandt DT, Schiffer M, and Kardinal C. (2008) Tyrosine phosphatase SHP-2 is a regulator of p27Kip1 tyrosine phosphorylation. Cell Cycle 7, 3858-3868.

Koch A, Scherr M, Breyer B, Mancini A, Kardinal C, Battmer K, Eder M, Tamura T. Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover. Oncogene 2008;27(34):4678-89.

Pierce, A., Carney L., Hamza HG, Griffiths JR, Zhang L., Whetton BA, Belen M., Sanchez G., Tamura, T., Sternberg D., and Whetton AD. (2008) Thoc5 splicesome protein: a target for leukaegenic tyrosine kinases that affects inositol lipid turnover. Br. J. Hematol. 141, 641-650.

Mancini, A., El Bounkari, O., Norrenbrock, A-F., Scherr, M., Schaefer, D., Eder M., Banham, A. H., Pulford, K., Lyne, L., Whetton A. D., and Tamura, T. (2007) FMIP controls the adipocyte lineage commitment of C2C12 cells by down-modulation of C/EBPalpha. Oncogene 26, 1020-1027.

Kardinal C., Dangers M., Kardinal A., Brandt D.T., Koch A., Tamura T., and Welte K. (2005) Tyrosine phosphorylation modulates binding preference to cyclin-dependent kinases and subcellular localization of p27Kip1 in the acute promyelotic leukemia cell line NB4. Blood<//span>. 2006 Feb 1;107(3):1133-40.   

Koch A., Mancini A., El Bounkari O., and Tamura T. (2005) The SH2-domain-containing inositol 5-phosphatase (SHIP)-2 binds to c-Met directly via tyrosine residue 1356 and involves hepatocyte growth factor (HGF)-induced lamellipodium formation, cell scattering and cell spreading. Oncogene, 24, 3436-47.

Mancini A., Koch A., Whetton A.D., and Tamura T. (2004)The M-CSF receptor substrate and interacting protein FMIP is governed in its subcellular localization by protein kinase C-mediated phosphorylation and thereby potentiates M-CSF-mediated differentiation. Oncogene, 23, 6581-9.

Ohrt, Th., Mancini, A., Tamura, T. and Niedenthal, R. (2004) c-Cbl binds to tyrosine- phosphorylated neurotrophin receptor p75 and induces its ubiquitination. Cellular Signaling, 16, 1291-1298.

Tamura T, and Koch A. (2003) Application of green fluorescent protein. Gene Technology Hand Book ed. M. Muramatsu, T. Yamamoto, Yodo-sha Press. pp227-230.

Mancini A., Koch A., Wilms R., and Tamura T. (2002) The SH2-containing inositol 5-phosphatase (SHIP)-1 is implicated in the control of cell-cell junction and induces dissociation and dispersion of MDCK cells. Oncogene, 21, 1477-84.

Mancini A., Koch A., Wilms R., and Tamura T.(2002) c-Cbl associates directly with the C-terminal tail of the receptor for macrophage colony-stimulating factor, c-fms, and down-regulates this receptor but not the viral oncogene v-Fms. J. Biol. Chem. 277 (17), 14635-40.

Tamura, T. and Mancini, A. (2002) Proto oncogens fms. Encyclopedia of Molecular Medicine. Ed, Glenn Collins, John Wiley & Sons, Inc., 1305 - 1307

Mancini,  A.,  Koch, A., Niemann, H.,  and Tamura, T. (2000) The direct association of the mutiple PDZ domain containing protein (MUPP) with the human c-Kit C- terminus is regulated by tyrosine kinase activity. FEBS letter, 482, 54-58.

Tamura,  T.,  Mancini, A., Joos,  H., Koch, A.,  Hakim,  C.,   Dumanski, J., Weidner, K.M.,   and Niemann, H. (1999) FMIP, a novel Fms-interacting protein, affects granulocyte/macrophage. Oncogene, 18, 6488-6495.

Decker  K., Koschinski A. Trouliaris S. Tamura, T., Dreyer, F., and Repp, H.  (1998) Activation of a Ca2+-dependent K+ current by the oncogenic receptor protein tyrosine kinase  v-fms in mouse fibroblasts. N-S. Arch. Pharmacol. 357, 378-384.

Mancini  A.,  Niedenthal,  R., Joos, H., Koch, A., Trouliaris, S.,  Niemann,  H.,  and Tamura, T.  (1997)  Identification of a second Grb2 binding site in the v-Fms  tyrosine kinase. Oncogene, 15, 1565-1572.

Joos, H., Trouliaris, S., Helftenbein, G., Niemann, H., and Tamura, T. (1996) Tyrosine phosphorylation of juxtamembrane domain of the v-Fms oncogene product and its associating proteins. J. Biol. Chem., 271, 24476-24481.

Helftenbein, G., Krusekopf, K., Just, U., Cross, M., Ostertag, W., Niemann, H. and Tamura, T. (1996) Transcriptional regulation of the c-fms proto-oncogene mediated by Granulocyte/macrophage colony stimulating factor (GM-CSF) in murine cell lines. Oncogene, 12, 931-935.

Trouliaris, S., Hadwiger-Fangmeier, A., Heimann, M., and Tamura, T. (1995)

Influence of tyrosine residues Y705 and Y807 on the transforming potency of the v-fms oncogene product of feline sarcoma virus. Arch. Virol. 140, 179-186.

Trouliaris, S., Smola, U., Chang, J.-H., Parsons, S. J., Niemann, H., and Tamura, T. (1995) Tyrosine  807  of  the v-Fms oncogene product  controls  cell  morphology  and association with p120RasGAP. J. Virol. 69, 6010-6020.

Just,  U., Friel, J., Heberlein. C., Tamura, T.,Baccarini, M., Tessmer,  U.,  Klingler, K., and Ostertag, W. (1993) Upregulation of lineage Specific Receptors and Ligands in Myeloid Stem Cells is part of an Endogenous Program  of  Differentiation.   Growth Factors, 9, 291-300.



Werden Sie Teil des Pflege-Teams der MHH. Mehr Infos in unserem Stellenticker. Wir freuen uns auf ...